Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Miro proteins prime mitochondria for Parkin translocation and mitophagy.

Safiulina D, Kuum M, Choubey V, Gogichaishvili N, Liiv J, Hickey MA, Cagalinec M, Mandel M, Zeb A, Liiv M, Kaasik A.

EMBO J. 2019 Jan 15;38(2). pii: e99384. doi: 10.15252/embj.201899384. Epub 2018 Nov 30.

2.

Wfs1- deficient rats develop primary symptoms of Wolfram syndrome: insulin-dependent diabetes, optic nerve atrophy and medullary degeneration.

Plaas M, Seppa K, Reimets R, Jagomäe T, Toots M, Koppel T, Vallisoo T, Nigul M, Heinla I, Meier R, Kaasik A, Piirsoo A, Hickey MA, Terasmaa A, Vasar E.

Sci Rep. 2017 Aug 31;7(1):10220. doi: 10.1038/s41598-017-09392-x.

3.

Role of Mitochondrial Dynamics in Neuronal Development: Mechanism for Wolfram Syndrome.

Cagalinec M, Liiv M, Hodurova Z, Hickey MA, Vaarmann A, Mandel M, Zeb A, Choubey V, Kuum M, Safiulina D, Vasar E, Veksler V, Kaasik A.

PLoS Biol. 2016 Jul 19;14(7):e1002511. doi: 10.1371/journal.pbio.1002511. eCollection 2016 Jul.

4.

BECN1 is involved in the initiation of mitophagy: it facilitates PARK2 translocation to mitochondria.

Choubey V, Cagalinec M, Liiv J, Safiulina D, Hickey MA, Kuum M, Liiv M, Anwar T, Eskelinen EL, Kaasik A.

Autophagy. 2014 Jun;10(6):1105-19. doi: 10.4161/auto.28615.

5.

Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.

Hickey MA, Zhu C, Medvedeva V, Lerner RP, Patassini S, Franich NR, Maiti P, Frautschy SA, Zeitlin S, Levine MS, Chesselet MF.

Mol Neurodegener. 2012 Apr 4;7:12. doi: 10.1186/1750-1326-7-12.

6.

Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease.

Lerner RP, Trejo Martinez Ldel C, Zhu C, Chesselet MF, Hickey MA.

Brain Res Bull. 2012 Apr 10;87(6):571-8. doi: 10.1016/j.brainresbull.2012.01.012. Epub 2012 Feb 4.

7.

A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.

Cummings DM, Alaghband Y, Hickey MA, Joshi PR, Hong SC, Zhu C, Ando TK, André VM, Cepeda C, Watson JB, Levine MS.

J Neurophysiol. 2012 Jan;107(2):677-91. doi: 10.1152/jn.00762.2011. Epub 2011 Nov 9.

8.

Evidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.

Hickey MA, Zhu C, Medvedeva V, Franich NR, Levine MS, Chesselet MF.

Mol Cell Neurosci. 2012 Feb;49(2):149-57. doi: 10.1016/j.mcn.2011.10.007. Epub 2011 Oct 20.

9.

Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington's Disease: Exercise, Adenosine Receptors and Ampakines.

Cepeda C, Cummings DM, Hickey MA, Kleiman-Weiner M, Chen JY, Watson JB, Levine MS.

PLoS Curr. 2010 Sep 20;2. pii: RRN1182. doi: 10.1371/currents.RRN1182.

10.

Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease.

Godin JD, Poizat G, Hickey MA, Maschat F, Humbert S.

EMBO J. 2010 Jul 21;29(14):2433-45. doi: 10.1038/emboj.2010.117. Epub 2010 Jun 8.

11.

Adipose tissue dysfunction tracks disease progression in two Huntington's disease mouse models.

Phan J, Hickey MA, Zhang P, Chesselet MF, Reue K.

Hum Mol Genet. 2009 Mar 15;18(6):1006-16. doi: 10.1093/hmg/ddn428. Epub 2009 Jan 5.

12.

Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Hickey MA, Kosmalska A, Enayati J, Cohen R, Zeitlin S, Levine MS, Chesselet MF.

Neuroscience. 2008 Nov 11;157(1):280-95. doi: 10.1016/j.neuroscience.2008.08.041. Epub 2008 Aug 27.

13.

Enhanced gene expression conferred by stepwise modification of a nonprimate lentiviral vector.

Sinn PL, Goreham-Voss JD, Arias AC, Hickey MA, Maury W, Chikkanna-Gowda CP, McCray PB Jr.

Hum Gene Ther. 2007 Dec;18(12):1244-52.

PMID:
18052720
14.

Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer.

Sinn PL, Burnight ER, Hickey MA, Blissard GW, McCray PB Jr.

J Virol. 2005 Oct;79(20):12818-27.

15.

Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing.

Hickey MA, Gallant K, Gross GG, Levine MS, Chesselet MF.

Neurobiol Dis. 2005 Oct;20(1):1-11.

PMID:
16137562
16.

Gene transfer to respiratory epithelia with lentivirus pseudotyped with Jaagsiekte sheep retrovirus envelope glycoprotein.

Sinn PL, Penisten AK, Burnight ER, Hickey MA, Williams G, McCoy DM, Mallampalli RK, McCray PB.

Hum Gene Ther. 2005 Apr;16(4):479-88.

PMID:
15871679
17.

Genetic mouse models of Huntington's and Parkinson's diseases: illuminating but imperfect.

Levine MS, Cepeda C, Hickey MA, Fleming SM, Chesselet MF.

Trends Neurosci. 2004 Nov;27(11):691-7. Review.

PMID:
15474170
18.

The use of transgenic and knock-in mice to study Huntington's disease.

Hickey MA, Chesselet MF.

Cytogenet Genome Res. 2003;100(1-4):276-86. Review.

PMID:
14526189
19.

Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha.

Sinn PL, Hickey MA, Staber PD, Dylla DE, Jeffers SA, Davidson BL, Sanders DA, McCray PB Jr.

J Virol. 2003 May;77(10):5902-10.

20.

Apoptosis in Huntington's disease.

Hickey MA, Chesselet MF.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 Apr;27(2):255-65. Review.

PMID:
12657365
21.

The role of dopamine in motor symptoms in the R6/2 transgenic mouse model of Huntington's disease.

Hickey MA, Reynolds GP, Morton AJ.

J Neurochem. 2002 Apr;81(1):46-59.

22.

Methamphetamine toxicity in mice is potentiated by exposure to loud music.

Morton AJ, Hickey MA, Dean LC.

Neuroreport. 2001 Oct 29;12(15):3277-81.

PMID:
11711870
23.

The epidemiology of Plasmodium falciparum malaria in two Cameroonian villages: Simbok and Etoa.

Quakyi IA, Leke RG, Befidi-Mengue R, Tsafack M, Bomba-Nkolo D, Manga L, Tchinda V, Njeungue E, Kouontchou S, Fogako J, Nyonglema P, Harun LT, Djokam R, Sama G, Eno A, Megnekou R, Metenou S, Ndountse L, Same-Ekobo A, Alake G, Meli J, Ngu J, Tietche F, Lohoue J, Mvondo JL, Wansi E, Leke R, Folefack A, Bigoga J, Bomba-Nkolo C, Titanji V, Walker-Abbey A, Hickey MA, Johnson AH, Taylor DW.

Am J Trop Med Hyg. 2000 Nov-Dec;63(5-6):222-30. Erratum in: Am J Trop Med Hyg. 2003 Mar;68(3):266. Ndoutse, L [corrected to Ndountse, L].

PMID:
11421368
25.

The critical incident technique applied to postgraduate training in psychiatry.

Graham JR, Winslow WW, Hickey MA.

Can Psychiatr Assoc J. 1972 Jun;17(3):177-81. No abstract available.

PMID:
4635839
26.

HOME VS. HOSPITAL CARE IN TUBERCULOSIS.

HICKEY MA.

Can Nurse. 1964 Apr;60:357-9. No abstract available.

PMID:
14138257

Supplemental Content

Loading ...
Support Center